Background
Methods
Study population
Data collection and measurement
Definitions
Statistical analysis
Results
Characteristics of the study population
Characteristics | EBG (n = 3440) | No EBG (n = 8048) | P-value |
---|---|---|---|
Men (%) | 37.6 | 34.2 | 0.001 |
Age (years) | 62.6 ± 10.5 | 56.4 ± 11.8 | < 0.001 |
Height (cm) | 158.3 ± 8.3 | 158.6 ± 8.2 | 0.079 |
Weight (kg) | 62.7 ± 11.1 | 59.5 ± 10.5 | < 0.001 |
BMI (kg cm− 2) | 25.0 ± 3.6 | 23.6 ± 3.4 | < 0.001 |
Waist circumference (cm) | 87.9 ± 9.9 | 82.9 ± 9.8 | < 0.001 |
Urban (n, %) | 1900, 55.2 | 3503, 43.5 | < 0.001 |
SBP (mmHg) | 137.8 ± 20.6 | 127.4 ± 19.7 | < 0.001 |
DBP (mmHg) | 82.7 ± 11.7 | 79.8 ± 11.5 | < 0.001 |
TG (mmol l− 1) | 2.1 ± 1.9 | 1.5 ± 1.2 | < 0.001 |
HDL (mmol l− 1) | 1.4 ± 0.4 | 1.6 ± 0.4 | < 0.001 |
CHOL (mmol l− 1) | 5.6 ± 1.2 | 5.4 ± 1.1 | < 0.001 |
LDL (mmol l− 1) | 3.7 ± 1.1 | 3.6 ± 1.0 | < 0.001 |
FPG (mmol l− 1) | 7.0 ± 2.2 | 5.0 ± 0.4 | < 0.001 |
Elevated waist circumference (%) | 67.5 | 48.0 | < 0.001 |
Elevated TG (%) | 45.4 | 28.2 | < 0.001 |
Reduced HDL (%) | 12.0 | 7.1 | < 0.001 |
Elevated BP (%) | 76.8 | 53.1 | < 0.001 |
Non-valvular AF (n, %) | 65, 1.9 | 79, 1.0 | < 0.001 |
Hyperthyroidism (n, %) | 170, 5.0 | 373, 4.6 | 0.473 |
COPD (n, %) | 203, 6.0 | 435, 5.4 | 0.286 |
Hypertension (n, %) | 1588, 46.2 | 1789, 22.2 | < 0.001 |
HUA (n, %) | 1675, 48.7 | 2875, 35.7 | < 0.001 |
CKD (n, %) | 514, 14.9 | 736, 9.1 | < 0.001 |
Smoking (n, %) | 763, 22.2 | 1704, 21.2 | 0.234 |
Alcohol consumption (n, %) | 719, 20.9 | 1732, 21.5 | 0.471 |
Tea consumption (n, %) | 2607, 75.8 | 5785, 71.9 | < 0.001 |
Prevalence of EBG among Guangzhou residents
Association between EBG and NVAF in the overall study population
Risk Factors | Univariable model | Age-adjusted model | ||
---|---|---|---|---|
OR (95% CI) | P-value | OR (95% CI) | P-value | |
Hypertension history | 3.52 (2.52–4.92) | < 0.001 | 2.21 (1.56–3.14) | < 0.001 |
T2D history | 2.33 (1.53–3.56) | < 0.001 | 1.29 (1.05–1.60) | 0.018 |
Hyperthyroidism | 2.20 (1.26–3.85) | 0.009 | 2.18 (1.24–3.82) | 0.007 |
COPD | 2.80 (1.73–4.52) | < 0.001 | 2.20 (1.36–3.57) | 0.001 |
Smoking | 1.36 (0.94–1.98) | 0.100 | 1.23 (0.85–1.79) | 0.273 |
Alcohol Consumption | 0.66 (0.42–1.04) | 0.085 | 0.74 (0.47–1.17) | 0.202 |
Tea Consumption | 1.03 (0.71–1.50) | 0.919 | 1.11 (0.77–1.62) | 0.575 |
Urban | 1.19 (0.86–1.66) | 0.292 | 1.10 (0.79–1.53) | 0.576 |
Models for the overall population | ||||
---|---|---|---|---|
Characteristics | Glucose Metabolism | |||
(N = 11,488) | Normal | EBG | T2D | IFG |
No. of NVAF/No. of participants | 79/8048 | 65/3440 | 32/1412 | 33/2028 |
Univariable-adjusted model | Referent | 1.94 (1.40–2.70) 0.000 | 2.34 (1.55–3.54) 0.000 | 1.67 (1.11–2.51) 0.014 |
Age-adjusted model | Referent | 1.44 (1.03–2.02) 0.032 | 1.65 (1.08–2.51) 0.019 | 1.29 (0.85–1.95) 0.231 |
Waist circumference-adjusted model | Referent | 1.71 (1.22–2.39) 0.002 | 2.00 (1.32–3.05) 0.001 | 1.50 (1.00–2.27) 0.053 |
BP-adjusted model | Referent | 1.65 (1.18–2.31) 0.004 | 1.94 (1.27–2.96) 0.002 | 1.44 (0.95–2.18) 0.084 |
TG-adjusted model | Referent | 2.04 (1.46–2.85) 0.000 | 2.50 (1.64–3.80) 0.000 | 1.74 (1.15–2.62) 0.009 |
HDL-adjusted model | Referent | 1.92 (1.37–2.67) 0.000 | 2.29 (1.51–3.48) 0.000 | 1.66 (1.10–2.49) 0.016 |
Waist circumference/BP/TG/HDL-adjusted model | Referent | 1.60 (1.14–2.25) 0.007 | 1.87 (1.22–2.87) 0.004 | 1.41 (0.93–2.14) 0.104 |
Models for the male population | ||||
Characteristics | Glucose Metabolism | |||
(N = 4047) | Normal | EBG | T2D | IFG |
No. of NVAF/No. of participants | 41/2754 | 30/1293 | 14/873 | 12/754 |
Univariable-adjusted model | Referent | 1.57 (0.98–2.53) 0.062 | 2.29 (1.30–4.01) 0.004 | 0.93 (0.48–1.80) 0.834 |
Age-adjusted model | Referent | 1.26 (0.78–2.04) 0.350 | 1.87 (1.06–3.30) 0.030 | 0.84 (0.44–1.62) 0.604 |
Waist circumference-adjusted model BP-adjusted model | Referent | 1.32 (0.82–2.15) 0.256 | 1.86 (1.05–3.29) 0.034 | 0.93 (0.49–1.79) 0.834 |
TG-adjusted model | Referent | 1.49 (0.92–2.41) 0.109 | 2.15 (1.21–3.81) 0.009 | 1.02 (0.53–1.96) 0.950 |
HDL-adjusted model | Referent | 1.62 (1.00–2.61) 0.048 | 2.37 (1.35–4.18) 0.003 | 1.10 (0.57–2.10) 0.779 |
Waist circumference/BP/TG/ | Referent | 1.56 (0.97–2.52) 0.066 | 2.27 (1.29–4.00) 0.004 | 1.07 (0.56–2.04) 0.842 |
HDL- adjusted model | Referent | 1.33 (0.81–2.17) 0.258 | 1.88 (1.05–3.35) 0.034 | 0.93 (0.48–1.80) 0.834 |
Models for the female population | ||||
Characteristics | Glucose Metabolism | |||
(N = 7441) | Normal | EBG | T2D | IFG |
No. of NVAF/No. of participants | 38/5294 | 35/2147 | 14/873 | 21/1274 |
Univariable-adjusted model | Referent | 2.29 (1.44–3.64) 0.001 | 2.25 (1.22–4.18) 0.010 | 2.32 (1.36–3.96) 0.002 |
Age-adjusted model | Referent | 1.63 (1.02–2.61) 0.041 | 1.45 (0.78–2.71) 0.245 | 1.78 (1.03–3.06) 0.038 |
Waist circumference-adjusted model BP-adjusted model | Referent | 1.97 (1.23–3.16) 0.005 | 1.88 (1.01–3.51) 0.048 | 2.04 (1.19–3.51) 0.010 |
TG-adjusted model | Referent | 1.78 (1.11–2.85) 0.017 | 1.69 (0.90–3.16) 0.101 | 1.85 (1.07–3.18) 0.027 |
HDL-adjusted model | Referent | 2.47 (1.54–3.95) 0.000 | 2.48 (1.32–4.66) 0.005 | 2.45 (1.43–4.22) 0.001 |
Waist circumference/BP/TG/ | Referent | 2.27 (1.43–3.62) 0.001 | 2.22 (1.19–4.14) 0.012 | 2.31 (1.35–3.95) 0.002 |
HDL- adjusted model | Referent | 1.80 (1.12–2.91) 0.016 | 1.71 (0.90–3.23) 0.099 | 1.86 (1.08–3.22) 0.026 |